Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Selinexor in Combination With Chemotherapy in Relapsed/Refractory Multiple Myeloma
NCT04877275Phase 2Recruiting
- Start
- May 2021
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of selinexor in multiple myeloma (MM). Started May 2021; status: recruiting.
02
Drugs
selinexor
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT04877275.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04877275.